IRIS
CALLEGARI, DONATELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 565
NA - Nord America 538
AS - Asia 164
Totale 1.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 537
IT - Italia 199
CN - Cina 118
IE - Irlanda 103
SE - Svezia 75
FR - Francia 69
FI - Finlandia 53
TR - Turchia 30
DE - Germania 28
VN - Vietnam 14
BE - Belgio 13
GB - Regno Unito 7
CZ - Repubblica Ceca 5
HR - Croazia 3
RO - Romania 3
AT - Austria 2
NL - Olanda 2
BG - Bulgaria 1
CA - Canada 1
IN - India 1
PL - Polonia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 1.267
Salva come PNG Salva come JPEG
Città #
Chandler 132
Ann Arbor 122
Dublin 103
Parma 59
Dearborn 41
New York 32
Izmir 26
Ashburn 24
Beijing 22
Nanjing 19
Shanghai 18
Princeton 16
Dong Ket 14
Wilmington 14
Bremen 13
Shenyang 11
Brussels 10
Los Angeles 9
Modena 9
Jinan 7
Follonica 6
San Mateo 6
Soliera 6
Woodbridge 6
Boardman 5
Brescia 5
Helsinki 5
Prata Di Pordenone 5
Grafing 4
Jiaxing 4
Kunming 4
Rome 4
Sant'ilario D'enza 4
Ankara 3
Borås 3
Caorso 3
Düsseldorf 3
Fremont 3
Guangzhou 3
Hebei 3
Hefei 3
Nanchang 3
Norwalk 3
Seattle 3
Trento 3
Vigevano 3
Zagreb 3
Bergamo 2
Brno 2
Carpi 2
Changsha 2
Fairfield 2
Hangzhou 2
Houston 2
Milan 2
Montegaldella 2
Palermo 2
Redmond 2
Rimini 2
Saviano 2
Trieste 2
Vienna 2
Zhengzhou 2
Alessandria 1
Bari 1
Bologna 1
Chaoyang 1
Charlottesville 1
Chengdu 1
Chicago 1
Chongqing 1
Des Moines 1
Edinburgh 1
Erlangen 1
Frankfurt am Main 1
Frontone 1
Fuzhou 1
Istanbul 1
Jacksonville 1
Kraków 1
La Villa 1
Leuven 1
Louvain 1
Múggia 1
Ottawa 1
Parabita 1
Paris 1
Pavia 1
Philadelphia 1
Pune 1
Reggio Nell'emilia 1
Rho 1
Saint Louis 1
San Giuliano Milanese 1
Shaoxing 1
Simi Valley 1
Sofia 1
Taiyuan 1
Tianjin 1
Viterbo 1
Totale 876
Salva come PNG Salva come JPEG
Nome #
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR 194
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 114
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 110
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 102
The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells 83
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 79
Eph-ephrin antagonism in tumor angiogenesis and growth: UniPR1331 preclinical evidence. 77
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 74
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 72
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists 67
N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations 63
L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib 62
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 61
Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8. 59
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 57
Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations 47
Totale 1.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 0 31 2
2019/2020260 45 19 5 8 18 49 33 11 24 27 10 11
2020/2021195 10 6 20 30 14 11 15 9 39 9 6 26
2021/2022151 4 6 9 25 3 10 27 9 2 12 10 34
2022/2023410 35 51 26 44 38 43 3 26 119 4 19 2
2023/2024114 7 5 3 2 11 47 20 8 5 6 0 0
Totale 1.321